Common Shares Outstanding: The number of class A shares currently held by investors.
Oruka Therapeutics, Inc. (ORKA) had Common Shares Outstanding of 37.44M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-21.00M |
|
-- |
|
-- |
|
$25.09M |
|
$-25.09M |
|
$4.09M |
|
$-21.00M |
|
$-21.00M |
|
$-21.00M |
|
$-21.00M |
|
$-21.00M |
|
$-21.00M |
|
$-25.09M |
|
$-26.87M |
|
41.68M |
|
41.68M |
|
$-0.40 |
|
$-0.40 |
|
| Balance Sheet Financials | |
$352.08M |
|
$0.16M |
|
$25.03M |
|
$377.11M |
|
$11.72M |
|
-- |
|
$0.66M |
|
$12.39M |
|
$361.79M |
|
$364.73M |
|
$364.73M |
|
|
Common Shares Outstanding |
37.44M |
| Cash Flow Statement Financials | |
$-20.87M |
|
$42.87M |
|
-- |
|
$61.58M |
|
$83.57M |
|
$22.00M |
|
$4.88M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
30.03 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-20.88M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-5.80% |
|
-5.76% |
|
-5.57% |
|
-5.76% |
|
$9.74 |
|
$-0.50 |
|
$-0.50 |
|